MetLife Investment Management’s Express Scripts Holding Company ESRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-163,554
Closed -$15.5M 2636
2018
Q3
$15.5M Sell
163,554
-1,804
-1% -$154K 0.16% 117
2018
Q2
$12.8M Sell
165,358
-4,476
-3% -$336K 0.15% 123
2018
Q1
$11.7M Sell
169,834
-5,406
-3% -$412K 0.14% 139
2017
Q4
$13.1M Buy
+175,240
New +$11.2M 0.15% 129

Other funds holding ESRX

MetLife Investment Management's ESRX Position: Q4 2018 in Review

MetLife Investment Management sold out of Express Scripts Holding Company (ESRX) in Q4 2018, closing a stake of 163,554 shares — an estimated $15.5M sold.

MetLife Investment Management first reported a position in ESRX in Q4 2017 and held it in 4 quarters. The position peaked at $15.5M in Q3 2018. 16 funds tracked by Wall St. Rank hold ESRX as of Q4 2018.

  • MetLife Investment Management reported no remaining Express Scripts Holding Company position as of Q4 2018 after selling out during the quarter.
  • MetLife Investment Management sold 163,554 Express Scripts Holding Company shares in Q4 2018, an estimated $15.5M.
  • MetLife Investment Management first reported a position in Express Scripts Holding Company in Q4 2017 and held it in 4 quarters.
  • MetLife Investment Management's Express Scripts Holding Company position peaked at $15.5M in Q3 2018.
  • 16 funds tracked by Wall St. Rank held Express Scripts Holding Company as of Q4 2018.

Based on MetLife Investment Management's 13F filing for Q4 2018, filed 14 Feb 2019.